| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/28/264:05 PM | -$0.10 | $0.47 | +570% | +394% | $168.2M | $211.0M | +25.5% | +58% | |
| Q2 '26 | 7/29/264:05 PM | -$0.23 | -$0.14 | +39.1% | +42% | $150.7M | $185.6M | +23.1% | +50% | |
| Q1 '26 | 4/29/264:05 PM | -$0.28 | -$0.18 | +35.7% | +18% | $137.0M | $150.6M | +9.9% | +41% | |
| Q4 '25 | 2/17/264:05 PM | -$0.21 | -$0.28 | -33.3% | +30% | $137.9M | $143.1M | +3.8% | +36% | |
| Q3 '25 | 10/29/254:05 PM | -$0.26 | -$0.16 | +38.5% | +43% | $122.3M | $133.5M | +9.2% | +38% | |
| Q2 '25 | 7/30/254:05 PM | -$0.26 | -$0.24 | +7.7% | +54% | $115.2M | $124.1M | +7.7% | +30% | |
| Q1 '25 | 4/30/254:05 PM | -$0.35 | -$0.22 | +37.1% | +69% | $102.8M | $106.7M | +3.8% | +25% |